Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14633675rdf:typepubmed:Citationlld:pubmed
pubmed-article:14633675lifeskim:mentionsumls-concept:C0038975lld:lifeskim
pubmed-article:14633675lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:14633675lifeskim:mentionsumls-concept:C0162326lld:lifeskim
pubmed-article:14633675lifeskim:mentionsumls-concept:C0022341lld:lifeskim
pubmed-article:14633675pubmed:issue22lld:pubmed
pubmed-article:14633675pubmed:dateCreated2003-11-24lld:pubmed
pubmed-article:14633675pubmed:abstractTextRecent studies showed that SV40 is detected in >40% of non-Hodgkin's lymphoma (NHL) in United States, suggesting SV40-contaminated poliovaccines widely used during the period 1955-1963 to be a major source of SV40 in NHL. We examined the presence of SV40 sequences in 122 cases with NHL and 3 with Hodgkin's lymphoma from Japan. The detection rate of SV40 sequences in diffuse large B-cell lymphoma (19%) was higher than that in peripheral blood cells of normal healthy volunteers in Japan (4.7%; P < 0.05) reported previously as controls for comparison with the study results from cancer patients, suggesting a role for SV40 in the development of diffuse large B-cell lymphoma. In contrast, the frequency of SV40 sequences in NHL cases born between 1951 and 1963 (12%), during which SV40-contaminated poliovaccines might have been inoculated, is not significantly different from that in cases born before 1950 (11%) or after 1964 (15%). SV40 is a new candidate etiologic factor for malignant lymphoma not only in the United States but also in Japan.lld:pubmed
pubmed-article:14633675pubmed:languageenglld:pubmed
pubmed-article:14633675pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14633675pubmed:citationSubsetIMlld:pubmed
pubmed-article:14633675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14633675pubmed:statusMEDLINElld:pubmed
pubmed-article:14633675pubmed:monthNovlld:pubmed
pubmed-article:14633675pubmed:issn0008-5472lld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:NakatsukaShin...lld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:TakakuwaTetsu...lld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:AozasaKatsuyu...lld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:NomuraShintar...lld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:MiyazatoHajim...lld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:DongZhimingZlld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:Osaka...lld:pubmed
pubmed-article:14633675pubmed:authorpubmed-author:LiuAngenAlld:pubmed
pubmed-article:14633675pubmed:issnTypePrintlld:pubmed
pubmed-article:14633675pubmed:day15lld:pubmed
pubmed-article:14633675pubmed:volume63lld:pubmed
pubmed-article:14633675pubmed:ownerNLMlld:pubmed
pubmed-article:14633675pubmed:authorsCompleteYlld:pubmed
pubmed-article:14633675pubmed:pagination7606-8lld:pubmed
pubmed-article:14633675pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:meshHeadingpubmed-meshheading:14633675...lld:pubmed
pubmed-article:14633675pubmed:year2003lld:pubmed
pubmed-article:14633675pubmed:articleTitleSimian virus 40 sequences in malignant lymphomas in Japan.lld:pubmed
pubmed-article:14633675pubmed:affiliationDepartment of Pathology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.lld:pubmed
pubmed-article:14633675pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14633675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14633675lld:pubmed